UNIGE document Scientific Article - Review
previous document  unige:41720  next document
add to browser collection

Phéochromocytome et paragangliome : que doit retenir le praticien ?

Published in Revue médicale suisse. 2014, vol. 10, no. 441, p. 1650-2,1654-5
Abstract Pheochromocytomas (PHEO) and paragangliomas (PGL) are rare neuroendocrine tumors secreting catecholamines in most cases. The clinic can be very variable. Morbidity and mortality PHEO and PGL are primarily cardiovascular and haves catecholamine-mediated origin. The PHEO and PGL can sign in with a syndromic association with multiple tumors and genetic counseling is necessary in search of a germline mutation. The first step includes a diagnostic assay of metanephrine and normetanephrines. In case of positive biology a CT or MRI imaging will be needed to locate the tumor. Treatment with alpha-blocker before surgery reduces the perioperative risk. A long term follow up is recommended to detect recurrence.
PMID: 25322623
Full text
Research groups Hypertension artérielle (128)
Mésothéliome pleural malin (944)
(ISO format)
LOOSLI, Nicolas et al. Phéochromocytome et paragangliome : que doit retenir le praticien ?. In: Revue médicale suisse, 2014, vol. 10, n° 441, p. 1650-2,1654-5. https://archive-ouverte.unige.ch/unige:41720

219 hits



Deposited on : 2014-11-12

Export document
Format :
Citation style :